Navigation Links
Human Genome Sciences Announces Third Quarter 2008 Financial Results and Key Developments
Date:11/6/2008

rom BLISS-76 anticipated in fall 2009. Assuming positive results from both studies, HGS expects to file a BLA in the United States in the first half of 2010. LymphoStat-B is being developed by HGS and GlaxoSmithKline (GSK) under a co-development and commercialization agreement entered into in August 2006.

ABthrax(TM): Awaiting U.S. Government Authorization to Begin Delivery to Strategic National Stockpile

HGS is currently awaiting U.S. Government authorization to begin delivery of 20,000 doses of ABthrax (raxibacumab) to the Strategic National Stockpile. ABthrax is being developed under contract with the Biomedical Advanced Research and Development Authority (BARDA) of the U.S. Department of Health and Human Services (HHS). HGS has met every milestone under its contract and previously expected that authorization would be received and delivery to the stockpile would commence in fall 2008 - in time to enable HGS to recognize $100-120 million in ABthrax sales in the fourth quarter of 2008. It now appears likely that these sales may instead be recognized in 2009, and the Company is updating its 2008 financial guidance accordingly. HGS is confident that it will receive $150 million in 2009 for delivery of 20,000 doses of ABthrax to the U.S. Strategic National Stockpile, with an additional $15 million expected upon FDA licensure.

Enrollment and Initial Dosing Completed in Non-Small Cell Lung Cancer Trial

In August 2008, HGS completed the enrollment and initial dosing of patients in a randomized Phase 2 trial of HGS-ETR1 (mapatumumab) in combination with the chemotherapy agents paclitaxel and carboplatin as first- line therapy in advanced non-small cell lung cancer (NSCLC). HGS expects initial data from this study in 2009. The results of the NSCLC trial, along with the results of ongoing randomized Phase 2 studies of HGS-ETR1 in advanced hepatocellular cancer and advanced multiple myeloma, will support a decision on whether to advance HGS-ETR1 t
'/>"/>

SOURCE Human Genome Sciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Data to Be Presented at 58th Annual Meeting of The American Society of Human Genetics
2. Ambrx to Present Phase I/II Clinical Data for Optimized, Long Acting Human Growth Hormone Analogue
3. Complete Genomics Chooses Isilon IQ to Power Worlds First Complete Human Genome Sequencing Service
4. Human Genome Sciences to Sponsor Conference Call to Discuss Third Quarter 2008 Financial Results
5. Human Pheromone Sciences, Inc. - Shareholder Update
6. The human brain minimizes energy expenditure and integrates gravity in to the action plan
7. EntreMeds ENMD-2076 Demonstrates Tumor Regression in Human Colon Cancer Model
8. Humanitarian Offers $75 Million for Single Dose Sterilization of Cats and Dogs
9. Pioneer(R) Surgical Technology Announces First Human Implants of New nanOss(TM)-Cervical Fusion Device
10. Complete Genomics Launches, Becomes Worlds First Large-Scale Human Genome Sequencing Company
11. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at JMP Securities Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)... Medical Innovations, Inc. (NYSE: IMA ), a global ... at home through the merger of rapid diagnostics and health ... its Series B Convertible Perpetual Preferred Stock ( IMA-PB). The ... in an amount per share equal to the quotient of ...
(Date:12/2/2009)... (Nasdaq: MATK ) announced today that it intends to ... 2009 on December 16, 2009, at approximately 4:00 p.m. Eastern ... Martek will conduct a conference call to discuss these results ... call live via webcast by visiting Martek,s web site at ...
(Date:12/2/2009)... Dec. 2 Reportlinker.com announces that a ... its catalogue: ,, Carbondioxide Incubators - ... http://www.reportlinker.com/p0164368/Carbondioxide-Incubators---A-Global-Market-Perspective.html ,, Incubators are the ... cancer, research, and other applications for providing ...
(Date:12/2/2009)... first concept demonstration tires made with BioIsoprene ... ingredient in the manufacture of synthetic rubber with renewable ... One tire will be on display at a lounge ... Airport throughout December 21, while the other tire will ...
Breaking Biology Technology:Martek to Announce Fourth Quarter and Fiscal Year 2009 Results 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 4The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 2The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 3
... July 31 Genta,Incorporated (OTC Bulletin Board: GNTA) ... quarter 2008 financial results on Thursday, August,7, 2008. ... live audio,webcast to discuss these financial results and ... access the live call by dialing (877) 634-8606 ...
... Calif., July 31 Alsius Corporation,(Nasdaq: ALUS ... therapies for critically ill patients, today,announced that it ... Company,s,second quarter results and provide a corporate update. ... beginning at 1:30 p.m. Pacific Time,(4:30 p.m. Eastern ...
... Cardinal Health, a,global provider of products and ... care, today announced a three-year agreement with,Prime Therapeutics, ... serve as its primary supply chain partner for ... Therapeutics managed more than $8.2 billion in prescription ...
Other Biology Technology:Genta Announces Second Quarter 2008 Financial Results and Conference Call 2Genta Announces Second Quarter 2008 Financial Results and Conference Call 3Alsius Corporation to Host Second Quarter 2008 Financial Results Conference Call on August 7 2Cardinal Health, Prime Therapeutics Sign Primary Distribution Agreement 2
(Date:12/3/2009)... repels grime and dirt? Expanded battery storage capacities for ... just published in Nature Nanotechnology , details a ... could make these futuristic visions come true in just ... 100 nanometers (roughly one-billionth of a meter) and even ...
(Date:12/3/2009)... Now in its 32nd year, the CTRC-AACR San ... in breast cancer science and world leaders from industry ... , This year, more than 8,500 scientists and ... Convention Center in San Antonio from Dec. 9-13, 2009. ...
(Date:12/3/2009)... Mich. (Dec. 3, 2009) Van Andel Research ... abscisic acid (ABA) works at the molecular level to help ... Their findings, published in the journal Nature , ... the world and combat global food shortages. The findings ...
Breaking Biology News(10 mins):A window that washes itself? 2CTRC-AACR San Antonio Breast Cancer Symposium continues to expand 2VAI researchers find long awaited key to creating drought resistant crops 2VAI researchers find long awaited key to creating drought resistant crops 3Cyberonics to Present at Canaccord Adams 29th Annual Global Growth Conference 53844 1Cyberonics to Present at Canaccord Adams 29th Annual Global Growth Conference 53844 2Green energy from algae 9497 1Green energy from algae 9497 2Green energy from algae 9497 3CBI Announces the Agenda for Their Upcoming Access Federal Stimulus Incentives for Electronic Health Records Conference 53841 1CBI Announces the Agenda for Their Upcoming Access Federal Stimulus Incentives for Electronic Health Records Conference 53841 2
... Eisei Noiri and colleagues at the University of Tokyo, Japan ... They present their data in the April 2009 issue of ... Acute kidney injury may be reversible if treated promptly and ... injury at early time points as well as to estimate ...
... 3.46 billion years old suggests that not only did the ... as oxygen rich as it is today, according to geologists. ... to the way this rock forms around hydrothermal vents in ... that the hematite in ancient rocks formed by the oxidation ...
... scientists from the National Institute of Oceanography and the ... research vessel Polarstern. The cooperative project Lohafex has yielded ... has dampened hopes on the potential of the Southern ... 2 ) and thus mitigate global warming. On 17 ...
Other Biology News:Tips from the American Journal of Pathology 2Tips from the American Journal of Pathology 3Tips from the American Journal of Pathology 4Tips from the American Journal of Pathology 5Deep-sea rocks point to early oxygen on Earth 2Lohafex provides new insights on plankton ecology 2Lohafex provides new insights on plankton ecology 3Lohafex provides new insights on plankton ecology 4
...
... Normal;heading 1;heading ... types and experimental ... for standard transfection ... transduction systems. ViraPower ...
LTBP-2 (7B10)...
... Rabbit polyclonal to Kv4.2 Immunogen ... corresponding to amino acids 23-43 of Rat ... with Rat.Expected to cross-react with Human (100% ... immunogen), Rabbit (100% identity with immunogen) and ...
Biology Products: